Although Hims & Hers gained much investor attention with its generic GLP-1 drug, the company is not just about weight loss medications and products. Hims & Hers caters to several other end markets, including sexual health, dermatology, and mental health. The company has announced new product additions to all these categories in the coming years, positioning it as a leading telehealth platform with a diversified product offering.